Treatment of refractory pemphigus erythematosus with rituximab.
Diab
Mohammad
M
Bechtel
Mark
M
Coloe
Jacquelyn
J
Kurtz
Eleanor
E
Ranalli
Mark
M
D000293:Adolescent; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D010392:Pemphigus / Q000188:drug therapy* / Q000473:pathology; D000069283:Rituximab
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D000069283:Rituximab